Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial.
Toyoda K, Koga M, Tanaka K, Uchiyama S, Sunami H, Omae K, Kimura K, Hoshino H, Fukuda-Doi M, Miwa K, Koge J, Okada Y, Sakai N, Minematsu K, Yamaguchi T; CSPS.com Trial Investigators. Toyoda K, et al. Among authors: omae k. Hypertens Res. 2024 Sep;47(9):2238-2249. doi: 10.1038/s41440-024-01742-3. Epub 2024 Jul 9. Hypertens Res. 2024. PMID: 38977876 Free PMC article. Clinical Trial.
Effect of cyborg-type robot Hybrid Assistive Limb on patients with severe walking disability in acute stroke: A randomized controlled study.
Yokota C, Tanaka K, Omae K, Kamada M, Nishikawa H, Koga M, Ihara M, Fujimoto Y, Sankai Y, Nakajima T, Minami M. Yokota C, et al. Among authors: omae k. J Stroke Cerebrovasc Dis. 2023 Apr;32(4):107020. doi: 10.1016/j.jstrokecerebrovasdis.2023.107020. Epub 2023 Jan 24. J Stroke Cerebrovasc Dis. 2023. PMID: 36701853 Free article. Clinical Trial.
Optimal antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis: study protocol for a randomized controlled trial.
Okazaki S, Yamamoto H, Asakura K, Omae K, Maeda H, Tanaka K, Yamamoto S, Hirano T, Iguchi Y, Sakaguchi M, Koga M, Ihara M, Toyoda K, Noguchi T, Sakai N, Yamagami H. Okazaki S, et al. Among authors: omae k. Front Neurol. 2024 Oct 23;15:1468523. doi: 10.3389/fneur.2024.1468523. eCollection 2024. Front Neurol. 2024. PMID: 39539664 Free PMC article.
Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial.
Yoshimoto T, Saito S, Omae K, Tanaka K, Kita T, Kitamura K, Fukuma K, Washida K, Abe S, Ishiyama H, Yamaguchi E, Yamagami H, Nagatsuka K, Tsuji M, Minami M, Yamamoto H, Hattori Y, Tanaka T, Ihara M. Yoshimoto T, et al. Among authors: omae k. EClinicalMedicine. 2024 Nov 13;77:102901. doi: 10.1016/j.eclinm.2024.102901. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39618942 Free PMC article.
Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study.
Nakao K, Noguchi T, Miura H, Asaumi Y, Morita Y, Takeuchi S, Matama H, Sawada K, Doi T, Hosoda H, Nakashima T, Honda S, Fujino M, Yoneda S, Kawakami S, Nagai T, Nishihira K, Kanaya T, Otsuka F, Nakanishi M, Kataoka Y, Tahara Y, Goto Y, Kusano K, Yamamoto H, Omae K, Ogawa H, Yasuda S. Nakao K, et al. Among authors: omae k. J Atheroscler Thromb. 2024 Feb 1;31(2):122-134. doi: 10.5551/jat.64063. Epub 2023 Sep 14. J Atheroscler Thromb. 2024. PMID: 37704431 Free PMC article. Clinical Trial.
A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Washida K, Saito S, Tanaka T, Nakaoku Y, Ishiyama H, Abe S, Kuroda T, Nakazawa S, Kakuta C, Omae K, Tanaka K, Minami M, Morita Y, Fukuda T, Shindo A, Maki T, Kitamura K, Tomimoto H, Aso T, Ihara M. Washida K, et al. Among authors: omae k. Cereb Circ Cogn Behav. 2024 Feb 6;6:100211. doi: 10.1016/j.cccb.2024.100211. eCollection 2024. Cereb Circ Cogn Behav. 2024. PMID: 38375188 Free PMC article.
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, Ishiguro C, Izumi C, Noguchi T, Shiraiwa T, Nishioka N, Fujii K, Iwakura K, Tomonaga O, Kobayashi K, Takihata M, Yumoto K, Takase H, Himi T, Shimizu I, Murakami T, Wagatsuma K, Sato K, Hiramatsu T, Akabame S, Hata S, Asakura M, Kawabata T, Omae K, Ito S, Kitakaze M; DAPPER Investigators. Yoshihara F, et al. Among authors: omae k. EClinicalMedicine. 2023 Nov 27;66:102334. doi: 10.1016/j.eclinm.2023.102334. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38192595 Free PMC article.
356 results